Suven Life Sciences jumps on securing two product patents from Europe

08 Aug 2013 Evaluate

Suven Life Sciences is currently trading at Rs. 27.20, up by 0.50 points or 1.87% from its previous closing of Rs. 26.70 on the BSE.

The scrip opened at Rs. 26.10 and has touched a high and low of Rs. 27.90 and Rs. 26.00 respectively. So far 1, 35,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 35.25 on 13-Dec-2012 and a 52 week low of Rs. 15.20 on 08-Aug-2012.

Last one week high and low of the scrip stood at Rs. 27.25 and Rs. 22.70 respectively. The current market cap of the company is Rs. 317 crore.

The promoters holding in the company stood at 64.76%, while Institutions and Non-Institutions held 0.07% and 35.17% respectively.

Suven Life Sciences has been granted two product patents from Europe corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases. These patents are valid through 2023 and 2029.

The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents and will be useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia.

With these new patents, Suven has a total of thirteen granted patents from Europe. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts. Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets.

Suven Life Sciences Share Price

168.90 4.75 (2.89%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×